Flow-diagram of patient identification. Patients with a diagnosis of... | Download Scientific Diagram
Blood biomarkers for differential diagnosis and early detection of pancreatic cancer - ScienceDirect
Early detection of pancreatic cancer - The Lancet Gastroenterology & Hepatology
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
Diagnostics | Free Full-Text | Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples
Cureus | Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances | Article
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data - eClinicalMedicine
Cancers | Free Full-Text | Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
Pancreatic Cancer (Pancreatic Ductal Adenocarcinoma) - CTA
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Cancers | Free Full-Text | Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer
Harnessing the Microbiome for Pancreatic Cancer Immunotherapy: Trends in Cancer
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy - eBioMedicine
Biosensors | Free Full-Text | An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Frontiers | Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
Frontiers | Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers | Science Translational Medicine
Cancers | Free Full-Text | Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need
IJMS | Free Full-Text | Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer
Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade | Journal of Pancreatology
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports
